These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 31324877)
1. Cimp-Positive Status is More Representative in Multiple Colorectal Cancers than in Unique Primary Colorectal Cancers. Tapial S; Olmedillas-López S; Rueda D; Arriba M; García JL; Vivas A; Pérez J; Pena-Couso L; Olivera R; Rodríguez Y; García-Arranz M; García-Olmo D; González-Sarmiento R; Urioste M; Goel A; Perea J Sci Rep; 2019 Jul; 9(1):10516. PubMed ID: 31324877 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis. Ogino S; Brahmandam M; Kawasaki T; Kirkner GJ; Loda M; Fuchs CS Mod Pathol; 2006 Aug; 19(8):1083-90. PubMed ID: 16699497 [TBL] [Abstract][Full Text] [Related]
3. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels. Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. Nosho K; Irahara N; Shima K; Kure S; Kirkner GJ; Schernhammer ES; Hazra A; Hunter DJ; Quackenbush J; Spiegelman D; Giovannucci EL; Fuchs CS; Ogino S PLoS One; 2008; 3(11):e3698. PubMed ID: 19002263 [TBL] [Abstract][Full Text] [Related]
5. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway. Kim JH; Bae JM; Cho NY; Kang GH Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113 [TBL] [Abstract][Full Text] [Related]
6. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer. Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS Hum Pathol; 2007 Apr; 38(4):614-20. PubMed ID: 17270239 [TBL] [Abstract][Full Text] [Related]
7. IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53. Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Kirkner GJ; Fuchs CS; Ogino S Neoplasia; 2007 Dec; 9(12):1091-8. PubMed ID: 18084616 [TBL] [Abstract][Full Text] [Related]
8. Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer. Han SW; Lee HJ; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY Int J Cancer; 2013 May; 132(9):2209-16. PubMed ID: 23034738 [TBL] [Abstract][Full Text] [Related]
9. WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer. Kawasaki T; Ohnishi M; Suemoto Y; Kirkner GJ; Liu Z; Yamamoto H; Loda M; Fuchs CS; Ogino S Mod Pathol; 2008 Feb; 21(2):150-8. PubMed ID: 18084250 [TBL] [Abstract][Full Text] [Related]
10. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer. Kim JH; Cho NY; Bae JM; Kim KJ; Rhee YY; Lee HS; Kang GH Int J Clin Exp Pathol; 2015; 8(2):1920-8. PubMed ID: 25973084 [TBL] [Abstract][Full Text] [Related]
11. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Ogino S; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Kirkner GJ; Fuchs CS Int J Cancer; 2008 Jun; 122(12):2767-73. PubMed ID: 18366060 [TBL] [Abstract][Full Text] [Related]
12. The role of the CpG island methylator phenotype on survival outcome in colon cancer. Kang KJ; Min BH; Ryu KJ; Kim KM; Chang DK; Kim JJ; Rhee JC; Kim YH Gut Liver; 2015 Mar; 9(2):202-7. PubMed ID: 25167802 [TBL] [Abstract][Full Text] [Related]
13. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype. Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS Hum Pathol; 2007 Jun; 38(6):842-9. PubMed ID: 17350669 [TBL] [Abstract][Full Text] [Related]
14. The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases. Cohen SA; Yu M; Baker K; Redman M; Wu C; Heinzerling TJ; Wirtz RM; Charalambous E; Pentheroudakis G; Kotoula V; Kalogeras KT; Fountzilas G; Grady WM Clin Epigenetics; 2017; 9():46. PubMed ID: 28469732 [TBL] [Abstract][Full Text] [Related]
15. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer. Ogino S; Kawasaki T; Kirkner GJ; Suemoto Y; Meyerhardt JA; Fuchs CS Gut; 2007 Nov; 56(11):1564-71. PubMed ID: 17339237 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. Ogino S; Kawasaki T; Kirkner GJ; Kraft P; Loda M; Fuchs CS J Mol Diagn; 2007 Jul; 9(3):305-14. PubMed ID: 17591929 [TBL] [Abstract][Full Text] [Related]
17. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high. Ogino S; Kawasaki T; Kirkner GJ; Ohnishi M; Fuchs CS BMC Cancer; 2007 May; 7():72. PubMed ID: 17474983 [TBL] [Abstract][Full Text] [Related]
18. Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer. Tanaka N; Huttenhower C; Nosho K; Baba Y; Shima K; Quackenbush J; Haigis KM; Giovannucci E; Fuchs CS; Ogino S Am J Pathol; 2010 Dec; 177(6):2731-40. PubMed ID: 21037082 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer. Ogino S; Kawasaki T; Kirkner GJ; Ogawa A; Dorfman I; Loda M; Fuchs CS J Pathol; 2006 Oct; 210(2):147-54. PubMed ID: 16850502 [TBL] [Abstract][Full Text] [Related]